A new microRNA profiling service offered by Ambion claims to surpass any similar offerings in the market. It has been found that microRNAs are potentially useful in the diagnosis and treatment for many diseases like diabetes, viral infection and cancer.

According to the company, outsourcing this unique function to Ambion Services provides researchers easy access to powerful information that can accelerate time-to-discovery, which is typically less than two weeks turn-around time for a full analysis upon sample receipt.

A webcast on"Characterization of miRNAs in Cancer and Brain Differentiation", presented in Australia in October last year is still available.. Click here to view webcast.

[Source: Lab Technologist]